li_item_id stringlengths 7 30 | drug_name stringlengths 4 169 | li_drug_name stringlengths 4 169 ⌀ | li_form stringlengths 8 210 ⌀ | schedule_form stringlengths 21 261 ⌀ | brand_name stringlengths 3 88 ⌀ | program_code stringclasses 17
values | pbs_code stringlengths 3 6 | benefit_type_code stringclasses 4
values | caution_indicator stringclasses 2
values | note_indicator stringclasses 2
values | manner_of_administration stringclasses 25
values | maximum_prescribable_pack float64 0.08 200 ⌀ | maximum_quantity_units float64 1 2.1k ⌀ | number_of_repeats float64 0 140 ⌀ | organisation_id float64 7 2.49k ⌀ | manufacturer_code stringclasses 226
values | pack_size float64 1 1k ⌀ | pricing_quantity float64 1 1k ⌀ | pack_not_to_be_broken_ind stringclasses 2
values | claimed_price float64 0.75 2.53M ⌀ | determined_price float64 0.75 2.53M ⌀ | determined_qty stringclasses 2
values | safety_net_resupply_rule_days float64 4 50 ⌀ | safety_net_resup_rule_cnt_ind stringclasses 2
values | extemporaneous_indicator stringclasses 2
values | extemporaneous_standard stringclasses 14
values | doctors_bag_group_id float64 1 62 ⌀ | section100_only_indicator stringclasses 2
values | doctors_bag_only_indicator stringclasses 2
values | brand_substitution_group_id float64 14.6k 29.7k ⌀ | brand_substitution_group_code stringclasses 2
values | supply_only_indicator stringclasses 2
values | supply_only_date stringclasses 9
values | non_effective_date stringclasses 3
values | weighted_avg_disclosed_price float64 | originator_brand_indicator stringclasses 2
values | paper_med_chart_eligible_ind stringclasses 2
values | elect_med_chart_eligible_ind stringclasses 2
values | hsptl_med_chart_eligible_ind stringclasses 2
values | paper_med_chart_duration float64 4 4 ⌀ | elect_med_chart_duration float64 6 6 ⌀ | hsptl_chart_acute_duration float64 12 12 ⌀ | hsptl_chart_sub_acute_duration float64 12 12 ⌀ | hsptl_chart_chronic_duration float64 12 12 ⌀ | pack_content float64 1 20k ⌀ | vial_content float64 1 15k ⌀ | infusible_indicator stringclasses 2
values | unit_of_measure stringclasses 6
values | continued_dispensing_flag stringclasses 2
values | continued_dispensing_emergency stringclasses 1
value | maximum_amount float64 2 30k ⌀ | formulary stringclasses 3
values | water_added_ind stringclasses 2
values | section_19a_expiry_date stringclasses 16
values | container_fee_type stringclasses 2
values | policy_applied_imdq60_base_flag stringclasses 2
values | policy_applied_imdq60_flag stringclasses 2
values | policy_applied_bio_sim_up_flag stringclasses 1
value | policy_applied_indig_phar_flag stringclasses 2
values | therapeutic_exemption_indicator stringclasses 2
values | premium_exemption_group_id float64 1.34k 1.34k ⌀ | doctors_bag_group_title stringclasses 1
value | therapeutic_group_id float64 1.34k 1.34k ⌀ | therapeutic_group_title stringclasses 1
value | advanced_notice_date stringclasses 3
values | supply_only_end_date stringclasses 8
values | first_listed_date stringdate 1991-08-01 00:00:00 2025-05-01 00:00:00 ⌀ | legal_unar_ind stringclasses 2
values | legal_car_ind stringclasses 2
values | schedule_code int64 3.67k 3.67k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1007B_11093_129_1426_9870 | Aciclovir | Aciclovir | Tablet 200 mg | aciclovir 200 mg tablet, 90 | Aciclovir GH | GE | 1007B | S | N | Y | ORAL | 1 | 90 | 5 | 145 | GQ | 90 | 25 | N | 16.92 | 4.7 | N | 20 | Y | N | null | null | N | N | 19,702 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2012-01-01 | N | N | 3,671 |
10080M_13909_30717_30720_30722 | Clobetasol | Clobetasol | Shampoo containing clobetasol propionate 500 microgram per mL, 125 mL | clobetasol propionate 0.05% shampoo, 125 mL | Clobex | GE | 10080M | S | N | N | APPLICATION | 1 | 1 | 1 | 7 | GA | 1 | 1 | Y | 31.66 | 31.66 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2014-04-01 | N | N | 3,671 |
10081N_12337_1373_5891_7177 | Tocilizumab | Tocilizumab | Concentrate for injection 80 mg in 4 mL | tocilizumab 80 mg/4 mL injection, 4 mL vial | Actemra | HB | 10081N | A | N | Y | INJECTION | 1 | 1 | 0 | 102 | RO | 1 | 1 | N | 82.19 | 82.19 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-04-01 | N | Y | 3,671 |
10082P_13910_30628_30629_30633 | Panitumumab | Panitumumab | Solution concentrate for I.V. infusion 100 mg in 5 mL | panitumumab 100 mg/5 mL injection, 5 mL vial | Vectibix | IP | 10082P | S | N | Y | INJECTION | null | null | 5 | 43 | AN | 1 | 1 | N | 450.42 | 450.42 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 100 | 100 | Y | mg | N | N | 720 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-04-01 | N | N | 3,671 |
10082P_13911_30628_30636_30638 | Panitumumab | Panitumumab | Solution concentrate for I.V. infusion 400 mg in 20 mL | panitumumab 400 mg/20 mL injection, 20 mL vial | Vectibix | IP | 10082P | S | N | Y | INJECTION | null | null | 5 | 43 | AN | 1 | 1 | N | 1,801.67 | 1,801.67 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 400 | 400 | Y | mg | N | N | 720 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | N | 3,671 |
10083Q_13920_30778_30779_30783 | Plerixafor | Plerixafor | Injection 24 mg in 1.2 mL | plerixafor 24 mg/1.2 mL injection, 1.2 mL vial | Mozobil | HB | 10083Q | S | N | Y | INJECTION | 1 | 1 | 1 | 42 | GZ | 1 | 1 | N | 4,016.84 | 4,016.84 | N | 4 | N | N | null | null | Y | N | 26,647 | a | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-05-01 | N | N | 3,671 |
10083Q_13920_30778_30779_54709 | Plerixafor | Plerixafor | Injection 24 mg in 1.2 mL | plerixafor 24 mg/1.2 mL injection, 1.2 mL vial | Plerixafor ARX | HB | 10083Q | S | N | Y | INJECTION | 1 | 1 | 1 | 1,908 | XT | 1 | 1 | N | 4,016.84 | 4,016.84 | N | 4 | N | N | null | null | Y | N | 26,647 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2022-10-01 | N | N | 3,671 |
10083Q_13920_30778_30779_58055 | Plerixafor | Plerixafor | Injection 24 mg in 1.2 mL | plerixafor 24 mg/1.2 mL injection, 1.2 mL vial | PLERIXAFOR EUGIA | HB | 10083Q | S | N | Y | INJECTION | 1 | 1 | 1 | 2,391 | YG | 1 | 1 | N | 4,016.84 | 4,016.84 | N | 4 | N | N | null | null | Y | N | 26,647 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-06-01 | N | N | 3,671 |
10084R_13920_30778_30779_30783 | Plerixafor | Plerixafor | Injection 24 mg in 1.2 mL | plerixafor 24 mg/1.2 mL injection, 1.2 mL vial | Mozobil | HS | 10084R | S | N | Y | INJECTION | 1 | 1 | 1 | 42 | GZ | 1 | 1 | N | 4,016.84 | 4,016.84 | N | 4 | N | N | null | null | Y | N | 26,646 | a | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-05-01 | N | N | 3,671 |
10084R_13920_30778_30779_54709 | Plerixafor | Plerixafor | Injection 24 mg in 1.2 mL | plerixafor 24 mg/1.2 mL injection, 1.2 mL vial | Plerixafor ARX | HS | 10084R | S | N | Y | INJECTION | 1 | 1 | 1 | 1,908 | XT | 1 | 1 | N | 4,016.84 | 4,016.84 | N | 4 | N | N | null | null | Y | N | 26,646 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2022-10-01 | N | N | 3,671 |
10084R_13920_30778_30779_58055 | Plerixafor | Plerixafor | Injection 24 mg in 1.2 mL | plerixafor 24 mg/1.2 mL injection, 1.2 mL vial | PLERIXAFOR EUGIA | HS | 10084R | S | N | Y | INJECTION | 1 | 1 | 1 | 2,391 | YG | 1 | 1 | N | 4,016.84 | 4,016.84 | N | 4 | N | N | null | null | Y | N | 26,646 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-06-01 | N | N | 3,671 |
10086W_14451_30407_32573_32575 | Sapropterin | Sapropterin | Tablet (soluble) containing sapropterin dihydrochloride 100 mg | sapropterin dihydrochloride 100 mg soluble tablet, 30 | Kuvan | GE | 10086W | A | N | Y | ORAL | 6 | 180 | 0 | 737 | IO | 30 | 30 | N | 776.15 | 776.15 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-05-01 | N | N | 3,671 |
10087X_14451_30407_32573_32575 | Sapropterin | Sapropterin | Tablet (soluble) containing sapropterin dihydrochloride 100 mg | sapropterin dihydrochloride 100 mg soluble tablet, 30 | Kuvan | GE | 10087X | A | N | Y | ORAL | 6 | 180 | 5 | 737 | IO | 30 | 30 | N | 776.15 | 776.15 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-05-01 | N | N | 3,671 |
10089B_13951_1337_30859_30861 | Sitagliptin + metformin | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | sitagliptin 100 mg + metformin hydrochloride 1 g tablet: modified release, 28 | Janumet XR | GE | 10089B | S | N | Y | ORAL | 1 | 28 | 5 | 1,908 | XW | 28 | 28 | N | 29.48 | 29.48 | N | 20 | Y | N | null | null | N | N | 28,131 | a | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-05-01 | N | N | 3,671 |
10089B_13951_1337_30859_57093 | Sitagliptin + metformin | Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | sitagliptin 100 mg + metformin hydrochloride 1 g tablet: modified release, 28 | Sitagliptin/Metformin Sandoz XR | GE | 10089B | S | N | Y | ORAL | 1 | 28 | 5 | 90 | SZ | 28 | 28 | N | 29.48 | 29.48 | N | 20 | Y | N | null | null | N | N | 28,131 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2023-12-01 | N | N | 3,671 |
10090C_8907_1337_32670_32672 | Sitagliptin + metformin | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | sitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56 | Janumet XR | GE | 10090C | S | N | Y | ORAL | 1 | 56 | 5 | 1,908 | XW | 56 | 56 | N | 30.47 | 30.47 | N | 20 | Y | N | null | null | N | N | 28,124 | a | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-05-01 | N | N | 3,671 |
10090C_8907_1337_32670_57095 | Sitagliptin + metformin | Sitagliptin with metformin | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | sitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56 | Sitagliptin/Metformin Sandoz XR | GE | 10090C | S | N | Y | ORAL | 1 | 56 | 5 | 90 | SZ | 56 | 56 | N | 30.47 | 30.47 | N | 20 | Y | N | null | null | N | N | 28,124 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2023-12-01 | N | N | 3,671 |
10091D_13894_30645_32260_32264 | Tapentadol | Tapentadol | Tablet (modified release) 200 mg (as hydrochloride) | tapentadol 200 mg modified release tablet, 28 | Palexia SR | GE | 10091D | S | Y | Y | ORAL | 1 | 28 | 0 | 96 | CS | 28 | 28 | N | 28.14 | 28.14 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10092E_13895_30645_32265_32269 | Tapentadol | Tapentadol | Tablet (modified release) 250 mg (as hydrochloride) | tapentadol 250 mg modified release tablet, 28 | Palexia SR | GE | 10092E | S | Y | Y | ORAL | 1 | 28 | 0 | 96 | CS | 28 | 28 | N | 32.89 | 32.89 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10093F_14193_1330_31591_31593 | arginine with carbohydrate | Arginine with carbohydrate | Sachets of oral powder 7.6 g containing 5 g arginine, 30 (Arginine 5000) | arginine with carbohydrate containing 5 g arginine powder for oral liquid, 30 x 7.6 g sachets | Arginine 5000 | GE | 10093F | R | N | Y | ORAL | 4 | 4 | 5 | 126 | VF | 1 | 1 | N | 194.35 | 194.35 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10094G_13891_30645_32250_32254 | Tapentadol | Tapentadol | Tablet (modified release) 100 mg (as hydrochloride) | tapentadol 100 mg modified release tablet, 28 | Palexia SR | GE | 10094G | S | Y | Y | ORAL | 1 | 28 | 0 | 96 | CS | 28 | 28 | N | 16.19 | 16.19 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10095H_12309_1386_5925_43883 | Dutasteride | Dutasteride | Capsule 500 micrograms | dutasteride 500 microgram capsule, 30 | APO-Dutasteride | R1 | 10095H | A | N | N | ORAL | 1 | 30 | 5 | 72 | TX | 30 | 30 | N | 15.22 | 15.22 | N | 4 | N | N | null | null | N | N | 21,869 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2018-07-01 | N | N | 3,671 |
10095H_12309_1386_5925_7214 | Dutasteride | Dutasteride | Capsule 500 micrograms | dutasteride 500 microgram capsule, 30 | Avodart | R1 | 10095H | A | N | N | ORAL | 1 | 30 | 5 | 66 | GK | 30 | 30 | N | 21.73 | 15.22 | N | 4 | N | N | null | null | N | N | 21,869 | a | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10096J_13892_30645_32270_32274 | Tapentadol | Tapentadol | Tablet (modified release) 50 mg (as hydrochloride) | tapentadol 50 mg modified release tablet, 28 | Palexia SR | GE | 10096J | S | Y | Y | ORAL | 1 | 28 | 0 | 96 | CS | 28 | 28 | N | 9.59 | 9.59 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10097K_14610_32794_32797_32799 | dressing hydrofibre with silver | Dressing hydrofibre with silver | Dressing 10 cm x 10 cm | dressing hydrofibre with silver 10 cm x 10 cm dressing, 10 | Aquacel Ag 403708 | R1 | 10097K | A | N | N | FOR_EXTERNAL_USE | 1 | 10 | 1 | 188 | CC | 10 | 10 | Y | 221.02 | 221.02 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | null | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10098L_14611_32794_32802_32804 | dressing hydrofibre with silver | Dressing hydrofibre with silver | Dressing 15 cm x 15 cm | dressing hydrofibre with silver 15 cm x 15 cm dressing, 5 | Aquacel Ag 403710 | R1 | 10098L | A | N | N | FOR_EXTERNAL_USE | 1 | 5 | 1 | 188 | CC | 5 | 5 | Y | 236.88 | 236.88 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | null | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
100G____ | Acetone (use as additive only) | null | null | null | null | EP | 100G | U | N | N | null | null | null | null | null | null | null | null | N | null | null | N | null | N | Y | BP | null | N | N | null | null | N | null | null | null | N | N | N | N | null | null | null | null | null | null | null | N | ml | N | N | null | null | N | null | null | N | N | N | N | N | null | null | null | null | null | null | null | N | N | 3,671 |
10100N_13893_30645_32255_32259 | Tapentadol | Tapentadol | Tablet (modified release) 150 mg (as hydrochloride) | tapentadol 150 mg modified release tablet, 28 | Palexia SR | GE | 10100N | S | Y | Y | ORAL | 1 | 28 | 0 | 96 | CS | 28 | 28 | N | 22.53 | 22.53 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10102Q_8112_1390_5929_7218 | Dutasteride + tamsulosin | Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | dutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30 | Duodart 500ug/400ug | R1 | 10102Q | A | N | N | ORAL | 1 | 30 | 5 | 66 | GK | 30 | 30 | N | 19.9 | 16.65 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10103R_7226_1119_5177_15084 | Exemestane | Exemestane | Tablet 25 mg | exemestane 25 mg tablet, 30 | Aromasin | GE | 10103R | R | N | N | ORAL | 1 | 30 | 5 | 69 | PF | 30 | 30 | N | 37.73 | 35.19 | N | 20 | N | N | null | null | N | N | 20,356 | a | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10103R_7226_1119_5177_15087 | Exemestane | Exemestane | Tablet 25 mg | exemestane 25 mg tablet, 30 | APO-Exemestane | GE | 10103R | R | N | N | ORAL | 1 | 30 | 5 | 72 | TX | 30 | 30 | N | 35.19 | 35.19 | N | 20 | N | N | null | null | N | N | 20,356 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10103R_7226_1119_5177_15088 | Exemestane | Exemestane | Tablet 25 mg | exemestane 25 mg tablet, 30 | Exemestane Sandoz | GE | 10103R | R | N | N | ORAL | 1 | 30 | 5 | 90 | SZ | 30 | 30 | N | 35.19 | 35.19 | N | 20 | N | N | null | null | N | N | 20,356 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10103R_7226_1119_5177_32759 | Exemestane | Exemestane | Tablet 25 mg | exemestane 25 mg tablet, 30 | Exemestane GH | GE | 10103R | R | N | N | ORAL | 1 | 30 | 5 | 145 | GQ | 30 | 30 | N | 35.19 | 35.19 | N | 20 | N | N | null | null | N | N | 20,356 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10103R_7226_1119_5177_58645 | Exemestane | Exemestane | Tablet 25 mg | exemestane 25 mg tablet, 30 | EXEMESTANE-WGR | GE | 10103R | R | N | N | ORAL | 1 | 30 | 5 | 2,410 | WG | 30 | 30 | N | 35.19 | 35.19 | N | 20 | N | N | null | null | N | N | 20,356 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2024-09-01 | N | N | 3,671 |
10104T_13914_30617_30622_30624 | Ferric carboxymaltose | Ferric carboxymaltose | Injection 500 mg (iron) in 10 mL | iron (as ferric carboxymaltose) 500 mg/10 mL injection, 10 mL vial | Ferinject | GE | 10104T | U | N | Y | INJECTION | 2 | 2 | 1 | 96 | CS | 1 | 1 | N | 122.74 | 122.74 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10105W_14612_32794_32807_32809 | dressing hydrofibre with silver | Dressing hydrofibre with silver | Ribbon 2 cm x 45 cm | dressing hydrofibre with silver 2 cm x 45 cm ribbon, 5 | Aquacel Ag 403771 | R1 | 10105W | A | N | N | FOR_EXTERNAL_USE | 1 | 5 | 1 | 188 | CC | 5 | 5 | Y | 186.03 | 186.03 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | null | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10106X_12892_1230_29367_29369 | Imiquimod | Imiquimod | Cream 50 mg per g, 2 g, 2 | imiquimod 5% cream, 2 x 2 g | Aldara Pump | R1 | 10106X | A | N | Y | APPLICATION | 1 | 1 | 1 | 1,348 | IL | 1 | 1 | N | 78.01 | 70.25 | N | 4 | N | N | null | null | N | N | 17,065 | a | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-06-01 | N | N | 3,671 |
10107Y_14390_1339_32354_32356 | Bimatoprost + timolol | Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30 | bimatoprost 0.03% + timolol 0.5% eye drops, 30 x 0.4 mL ampoules | GANfort PF 0.3/5 | GE | 10107Y | R | N | N | APPLICATION_TO_THE_EYE | 1 | 1 | 5 | 68 | VE | 1 | 1 | Y | 19.83 | 19.83 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | CDL | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2014-07-01 | N | N | 3,671 |
10108B_14390_1339_32354_32356 | Bimatoprost + timolol | Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30 | bimatoprost 0.03% + timolol 0.5% eye drops, 30 x 0.4 mL ampoules | GANfort PF 0.3/5 | GE | 10108B | R | N | Y | APPLICATION_TO_THE_EYE | 1 | 1 | 5 | 68 | VE | 1 | 1 | Y | 19.83 | 19.83 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | CDL | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2014-07-01 | N | N | 3,671 |
10109C_14736_1396_32614_32616 | Omalizumab | Omalizumab | Injection 150 mg in 1 mL single dose pre-filled syringe | omalizumab 150 mg/mL injection, 1 mL syringe | Xolair | HB | 10109C | A | N | Y | INJECTION | 1 | 1 | 7 | 25 | NV | 1 | 1 | N | 215.19 | 215.19 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10110D_14737_1396_32609_32611 | Omalizumab | Omalizumab | Injection 75 mg in 0.5 mL single dose pre-filled syringe | omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe | Xolair | HS | 10110D | A | N | Y | INJECTION | 1 | 1 | 7 | 25 | NV | 1 | 1 | N | 107.6 | 107.6 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10111E_14798_1238_33346_33348 | Epoprostenol | Epoprostenol | Powder for I.V. infusion 500 micrograms (as sodium) | epoprostenol 500 microgram injection, 1 vial | Veletri | HS | 10111E | A | N | Y | INJECTION | 30 | 30 | 5 | 63 | JC | 1 | 1 | N | 33.28 | 33.28 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10116K_14810_1166_32236_32238 | Progesterone | Progesterone | Vaginal tablet 100 mg | progesterone 100 mg pessary, 21 | Endometrin | IF | 10116K | S | N | Y | VAGINAL | 2 | 42 | 0 | 133 | FP | 21 | 21 | N | 31.21 | 31.21 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | N | 3,671 |
10117L_14797_1238_33343_33345 | Epoprostenol | Epoprostenol | Powder for I.V. infusion 1.5 mg (as sodium) | epoprostenol 1.5 mg injection, 1 vial | Veletri | HB | 10117L | A | N | Y | INJECTION | 30 | 30 | 5 | 63 | JC | 1 | 1 | N | 59.33 | 59.33 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10118M_14737_1396_32609_32611 | Omalizumab | Omalizumab | Injection 75 mg in 0.5 mL single dose pre-filled syringe | omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe | Xolair | HB | 10118M | A | N | Y | INJECTION | 1 | 1 | 7 | 25 | NV | 1 | 1 | N | 107.6 | 107.6 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10119N_14294_32044_32045_32049 | Betaine | Betaine | Oral powder 180 g | betaine 1 g/g powder for oral liquid, 180 g | Cystadane | GE | 10119N | A | N | Y | ORAL | 1 | 1 | 5 | 1,548 | RJ | 1 | 1 | Y | 455.03 | 455.03 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | N | 3,671 |
10122R_14736_1396_32614_32616 | Omalizumab | Omalizumab | Injection 150 mg in 1 mL single dose pre-filled syringe | omalizumab 150 mg/mL injection, 1 mL syringe | Xolair | HS | 10122R | A | N | Y | INJECTION | 1 | 1 | 7 | 25 | NV | 1 | 1 | N | 215.19 | 215.19 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10124W_14334_32210_32213_32215 | Aclidinium | Aclidinium | Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses | aclidinium 322 microgram/actuation inhalation: powder for, 60 actuations | Bretaris Genuair | GE | 10124W | R | N | Y | INHALATION_BY_MOUTH | 1 | 1 | 5 | 93 | FK | 1 | 1 | Y | 42.7 | 42.7 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | N | 3,671 |
10128C_14778_1395_33238_33240 | Saxagliptin | Saxagliptin | Tablet 2.5 mg (as hydrochloride) | saxagliptin 2.5 mg tablet, 28 | Onglyza | GE | 10128C | S | N | Y | ORAL | 1 | 28 | 5 | 76 | AP | 28 | 28 | N | 35.8 | 35.8 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | N | 3,671 |
10129D_14797_1238_33343_33345 | Epoprostenol | Epoprostenol | Powder for I.V. infusion 1.5 mg (as sodium) | epoprostenol 1.5 mg injection, 1 vial | Veletri | HS | 10129D | A | N | Y | INJECTION | 30 | 30 | 5 | 63 | JC | 1 | 1 | N | 59.33 | 59.33 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10130E_14798_1238_33346_33348 | Epoprostenol | Epoprostenol | Powder for I.V. infusion 500 micrograms (as sodium) | epoprostenol 500 microgram injection, 1 vial | Veletri | HB | 10130E | A | N | Y | INJECTION | 30 | 30 | 5 | 63 | JC | 1 | 1 | N | 33.28 | 33.28 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-08-01 | N | Y | 3,671 |
10131F_13606_1215_29836_29840 | Everolimus | Everolimus | Tablet 5 mg | everolimus 5 mg tablet, 30 | Afinitor | GE | 10131F | A | N | Y | ORAL | 1 | 30 | 5 | 25 | NV | 30 | 30 | N | 796.7 | 796.7 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | N | 3,671 |
10132G_13607_1215_29831_29835 | Everolimus | Everolimus | Tablet 10 mg | everolimus 10 mg tablet, 30 | Afinitor | GE | 10132G | A | N | Y | ORAL | 1 | 30 | 2 | 25 | NV | 30 | 30 | N | 1,593.4 | 1,593.4 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | N | 3,671 |
10133H_13606_1215_29836_29840 | Everolimus | Everolimus | Tablet 5 mg | everolimus 5 mg tablet, 30 | Afinitor | GE | 10133H | A | N | Y | ORAL | 1 | 30 | 2 | 25 | NV | 30 | 30 | N | 796.7 | 796.7 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | N | 3,671 |
10134J_14271_31875_31878_31880 | Macitentan | Macitentan | Tablet 10 mg | macitentan 10 mg tablet, 30 | Opsumit | HS | 10134J | A | Y | Y | ORAL | 1 | 30 | 5 | 63 | JC | 30 | 30 | N | 2,596.02 | 2,596.02 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | Y | 3,671 |
10135K_13607_1215_29831_29835 | Everolimus | Everolimus | Tablet 10 mg | everolimus 10 mg tablet, 30 | Afinitor | GE | 10135K | A | N | Y | ORAL | 1 | 30 | 5 | 25 | NV | 30 | 30 | N | 1,593.4 | 1,593.4 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | N | 3,671 |
10136L_14271_31875_31878_31880 | Macitentan | Macitentan | Tablet 10 mg | macitentan 10 mg tablet, 30 | Opsumit | HB | 10136L | A | Y | Y | ORAL | 1 | 30 | 5 | 63 | JC | 30 | 30 | N | 2,596.02 | 2,596.02 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | Y | 3,671 |
10137M_7398_1372_5888_7170 | Certolizumab pegol | Certolizumab pegol | Injection 200 mg in 1 mL single use pre-filled syringe | certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes | Cimzia | GE | 10137M | A | N | Y | INJECTION | 1 | 2 | 5 | 67 | UC | 2 | 2 | N | 952.13 | 952.13 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | N | 3,671 |
10138N_14470_1268_32621_32623 | Ranibizumab | Ranibizumab | Solution for intravitreal injection 1.65 mg in 0.165 mL pre-filled syringe | ranibizumab 1.65 mg/0.165 mL injection, 0.165 mL syringe | Lucentis | GE | 10138N | A | N | Y | INJECTION | 1 | 1 | 2 | 25 | NV | 1 | 1 | N | 689.04 | 689.04 | N | 4 | N | N | null | null | N | N | 17,312 | a | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-09-01 | N | N | 3,671 |
10140Q_13906_30696_30699_30701 | Eribulin | Eribulin | Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL | eribulin mesilate 1 mg/2 mL injection, 2 mL vial | Halaven | IN | 10140Q | S | N | Y | INJECTION | null | null | 13 | 109 | EI | 1 | 1 | N | 216.6 | 216.6 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 1 | 1 | Y | mg | N | N | 3 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-10-01 | N | N | 3,671 |
10144X_13906_30696_30699_30701 | Eribulin | Eribulin | Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL | eribulin mesilate 1 mg/2 mL injection, 2 mL vial | Halaven | IP | 10144X | S | N | Y | INJECTION | null | null | 13 | 109 | EI | 1 | 1 | N | 216.6 | 216.6 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 1 | 1 | Y | mg | N | N | 3 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-10-01 | N | N | 3,671 |
10146B_14636_1013_34396_34402 | estradiol (&) estradiol + dydrogesterone | Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg | estradiol 1 mg tablet [14] (&) estradiol 1 mg + dydrogesterone 10 mg tablet [14], 28 | Femoston 1/10 | GE | 10146B | U | N | Y | ORAL | 1 | 1 | 5 | 1,908 | XT | 1 | 1 | Y | 9.98 | 9.98 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | CDL | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2014-10-01 | N | N | 3,671 |
10148D_10053_954_4531_13614 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 80 mg in 8 mL | docetaxel 80 mg/8 mL injection, 8 mL vial | DBL Docetaxel Concentrated Injection | IP | 10148D | U | N | Y | INJECTION | null | null | 5 | 69 | PF | 1 | 1 | N | 24.12 | 24.12 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 80 | 80 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10148D_11429_954_4530_42603 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 80 mg in 4 mL | docetaxel 80 mg/4 mL injection, 4 mL vial | Docetaxel Accord | IP | 10148D | U | N | Y | INJECTION | null | null | 5 | 1,165 | OC | 1 | 1 | N | 16.68 | 16.68 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 80 | 80 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2017-06-01 | N | N | 3,671 |
10148D_21617_954_43231_43237 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 160 mg in 8 mL | docetaxel 160 mg/8 mL injection, 8 mL vial | Docetaxel Accord | IP | 10148D | U | N | Y | INJECTION | null | null | 5 | 1,165 | OC | 1 | 1 | N | 33.35 | 33.35 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 160 | 160 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2017-11-01 | N | N | 3,671 |
10148D_8673_954_4527_13606 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 160 mg in 16 mL | docetaxel 160 mg/16 mL injection, 16 mL vial | DBL Docetaxel Concentrated Injection | IP | 10148D | U | N | Y | INJECTION | null | null | 5 | 69 | PF | 1 | 1 | N | 48.24 | 48.24 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 160 | 160 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10149E_15052_1364_34698_34700 | vitamins, minerals and trace elements with carbohydrate | Vitamins, minerals and trace elements with carbohydrate | Sachets containing oral powder 6 g, 30 (FruitiVits) | vitamins, minerals and trace elements with carbohydrate powder for oral liquid, 30 x 6 g sachets | FruitiVits | GE | 10149E | R | N | Y | ORAL | 1 | 1 | 5 | 126 | VF | 1 | 1 | N | 218.28 | 218.28 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10150F_10927_1326_5782_59626 | nanoparticle albumin-bound paclitaxel | Paclitaxel, nanoparticle albumin-bound | Powder for I.V. injection containing 100 mg paclitaxel | paclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial | nab-PACLITAXEL JUNO | IN | 10150F | S | N | Y | INJECTION | null | null | 11 | 1,040 | JU | 1 | 1 | N | 287.13 | 287.13 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 100 | 100 | Y | mg | N | N | 275 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2025-02-01 | N | N | 3,671 |
10150F_10927_1326_5782_7044 | nanoparticle albumin-bound paclitaxel | Paclitaxel, nanoparticle albumin-bound | Powder for I.V. injection containing 100 mg paclitaxel | paclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial | Abraxane | IN | 10150F | S | N | Y | INJECTION | null | null | 11 | 110 | TS | 1 | 1 | N | 287.13 | 287.13 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 100 | 100 | Y | mg | N | N | 275 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10151G_15058_33283_33359_33361 | Perampanel | Perampanel | Tablet 10 mg (as hemisesquihydrate) | perampanel 10 mg tablet, 28 | Fycompa | GE | 10151G | S | N | Y | ORAL | 1 | 28 | 5 | 109 | EI | 28 | 28 | N | 248.38 | 248.38 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10152H_7640_15639_4841_14342 | triglycerides medium chain formula | Triglycerides - medium chain, formula | Oral powder 400 g (Monogen) | triglycerides medium chain formula powder for oral liquid, 400 g | Monogen | GE | 10152H | R | N | Y | ORAL | 8 | 8 | 5 | 152 | SB | 1 | 1 | N | 43.83 | 43.83 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10154K_15091_15639_4841_33394 | triglycerides medium chain formula | Triglycerides - medium chain, formula | Oral powder 400 g (Peptamen Junior) | triglycerides medium chain formula powder for oral liquid, 400 g | Peptamen Junior | GE | 10154K | R | N | Y | ORAL | 8 | 8 | 5 | 119 | NT | 1 | 1 | N | 28.43 | 28.43 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10155L_10414_15639_4841_14343 | triglycerides medium chain formula | Triglycerides - medium chain, formula | Oral powder 400 g (Lipistart) | triglycerides medium chain formula powder for oral liquid, 400 g | Lipistart | GE | 10155L | R | N | Y | ORAL | 8 | 8 | 5 | 126 | VF | 1 | 1 | N | 39.51 | 39.51 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10156M_14333_31943_31947_31949 | indacaterol + glycopyrronium | Indacaterol with glycopyrronium | Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) | indacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 30 capsules | ultibro breezhaler 110/50 | GE | 10156M | S | N | Y | INHALATION_BY_MOUTH | 1 | 30 | 5 | 25 | NV | 30 | 30 | N | 68.39 | 68.39 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | CDL | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10157N_14799_33283_33288_33290 | Perampanel | Perampanel | Tablet 2 mg (as hemisesquihydrate) | perampanel 2 mg tablet, 7 | Fycompa | GE | 10157N | S | N | N | ORAL | 2 | 14 | 1 | 109 | EI | 7 | 7 | N | 15.52 | 15.52 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10158P_10053_954_4531_13614 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 80 mg in 8 mL | docetaxel 80 mg/8 mL injection, 8 mL vial | DBL Docetaxel Concentrated Injection | IN | 10158P | U | N | Y | INJECTION | null | null | 5 | 69 | PF | 1 | 1 | N | 24.12 | 24.12 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 80 | 80 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10158P_11429_954_4530_42603 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 80 mg in 4 mL | docetaxel 80 mg/4 mL injection, 4 mL vial | Docetaxel Accord | IN | 10158P | U | N | Y | INJECTION | null | null | 5 | 1,165 | OC | 1 | 1 | N | 16.68 | 16.68 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 80 | 80 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2017-06-01 | N | N | 3,671 |
10158P_21617_954_43231_43237 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 160 mg in 8 mL | docetaxel 160 mg/8 mL injection, 8 mL vial | Docetaxel Accord | IN | 10158P | U | N | Y | INJECTION | null | null | 5 | 1,165 | OC | 1 | 1 | N | 33.35 | 33.35 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 160 | 160 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2017-11-01 | N | N | 3,671 |
10158P_8673_954_4527_13606 | Docetaxel | Docetaxel | Solution concentrate for I.V. infusion 160 mg in 16 mL | docetaxel 160 mg/16 mL injection, 16 mL vial | DBL Docetaxel Concentrated Injection | IN | 10158P | U | N | Y | INJECTION | null | null | 5 | 69 | PF | 1 | 1 | N | 48.24 | 48.24 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 160 | 160 | Y | mg | N | N | 250 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10159Q_15059_33283_33366_33368 | Perampanel | Perampanel | Tablet 12 mg (as hemisesquihydrate) | perampanel 12 mg tablet, 28 | Fycompa | GE | 10159Q | S | N | Y | ORAL | 1 | 28 | 5 | 109 | EI | 28 | 28 | N | 248.38 | 248.38 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10160R_15057_33283_33354_33356 | Perampanel | Perampanel | Tablet 8 mg (as hemisesquihydrate) | perampanel 8 mg tablet, 28 | Fycompa | GE | 10160R | S | N | Y | ORAL | 1 | 28 | 5 | 109 | EI | 28 | 28 | N | 248.38 | 248.38 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10161T_15112_35060_35063_35065 | amino acid formula without valine, leucine and isoleucine | Amino acid formula without valine, leucine and isoleucine | Sachets containing oral powder 6 g, 30 (MSUD amino5) | amino acid formula without valine, leucine and isoleucine containing 5 g of protein equivalent powder for oral liquid, 30 x 6 g sachets | MSUD amino5 | GE | 10161T | R | N | N | ORAL | 12 | 12 | 5 | 126 | VF | 1 | 1 | N | 222.02 | 222.02 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10162W_15055_33283_33369_33371 | Perampanel | Perampanel | Tablet 4 mg (as hemisesquihydrate) | perampanel 4 mg tablet, 28 | Fycompa | GE | 10162W | S | N | Y | ORAL | 1 | 28 | 5 | 109 | EI | 28 | 28 | N | 124.2 | 124.2 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10163X_15056_33283_33339_33351 | Perampanel | Perampanel | Tablet 6 mg (as hemisesquihydrate) | perampanel 6 mg tablet, 28 | Fycompa | GE | 10163X | S | N | Y | ORAL | 1 | 28 | 5 | 109 | EI | 28 | 28 | N | 186.3 | 186.3 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10165B_10927_1326_5782_59626 | nanoparticle albumin-bound paclitaxel | Paclitaxel, nanoparticle albumin-bound | Powder for I.V. injection containing 100 mg paclitaxel | paclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial | nab-PACLITAXEL JUNO | IP | 10165B | S | N | Y | INJECTION | null | null | 11 | 1,040 | JU | 1 | 1 | N | 287.13 | 287.13 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | 100 | 100 | Y | mg | N | N | 275 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2025-02-01 | N | N | 3,671 |
10165B_10927_1326_5782_7044 | nanoparticle albumin-bound paclitaxel | Paclitaxel, nanoparticle albumin-bound | Powder for I.V. injection containing 100 mg paclitaxel | paclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial | Abraxane | IP | 10165B | S | N | Y | INJECTION | null | null | 11 | 110 | TS | 1 | 1 | N | 287.13 | 287.13 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 100 | 100 | Y | mg | N | N | 275 | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-11-01 | N | N | 3,671 |
10166C_14432_32082_32107_32178 | Brentuximab vedotin | Brentuximab vedotin | Powder for I.V. infusion 50 mg | brentuximab vedotin 50 mg injection, 1 vial | Adcetris | IP | 10166C | A | N | Y | INJECTION | null | null | 3 | 104 | TK | 1 | 1 | N | 4,422.25 | 4,422.25 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 50 | 50 | Y | mg | N | N | 200 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10168E_10260_1313_5747_6986 | Voriconazole | Voriconazole | Powder for oral suspension 40 mg per mL, 70 mL | voriconazole 40 mg/mL powder for oral liquid, 70 mL | Vfend | GE | 10168E | A | N | Y | ORAL | 1 | 1 | 0 | 69 | PF | 1 | 1 | N | 439.14 | 439.14 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | Y | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10169F_9561_1072_15684_36068 | Clopidogrel | Clopidogrel | Tablet 75 mg (as besilate) | clopidogrel 75 mg tablet, 28 | Plidogrel | R1 | 10169F | A | N | Y | ORAL | 1 | 28 | 3 | 1,081 | RF | 28 | 28 | N | 3.8 | 3.8 | N | 4 | N | N | null | null | N | N | 15,826 | a | Y | 2024-12-01 | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | 2025-06-01 | 2018-01-01 | N | N | 3,671 |
1016L_11822_130_1441_10637 | Adrenaline (epinephrine) | Adrenaline (epinephrine) | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | adrenaline (epinephrine) 1 in 1000 (1 mg/mL) injection, 5 x 1 mL ampoules | Link Medical Products Pty Ltd | GE | 1016L | U | N | Y | INJECTION | 1 | 5 | 1 | 108 | LM | 5 | 5 | N | 7.11 | 7.11 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2011-06-01 | N | N | 3,671 |
10170G_13366_29107_29110_34911 | Ivacaftor | Ivacaftor | Tablet 150 mg | ivacaftor 150 mg tablet, 56 | Kalydeco | HB | 10170G | A | N | Y | ORAL | 1 | 56 | 5 | 417 | VR | 56 | 56 | N | 20,306.25 | 20,306.25 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10171H_14432_32082_32107_32178 | Brentuximab vedotin | Brentuximab vedotin | Powder for I.V. infusion 50 mg | brentuximab vedotin 50 mg injection, 1 vial | Adcetris | IP | 10171H | A | N | Y | INJECTION | null | null | 11 | 104 | TK | 1 | 1 | N | 4,422.25 | 4,422.25 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 50 | 50 | Y | mg | N | N | 200 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10172J_14432_32082_32107_32178 | Brentuximab vedotin | Brentuximab vedotin | Powder for I.V. infusion 50 mg | brentuximab vedotin 50 mg injection, 1 vial | Adcetris | IN | 10172J | A | N | Y | INJECTION | null | null | 3 | 104 | TK | 1 | 1 | N | 4,422.25 | 4,422.25 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 50 | 50 | Y | mg | N | N | 200 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10173K_8891_1313_5749_38850 | Voriconazole | Voriconazole | Tablet 50 mg | voriconazole 50 mg tablet, 56 | Voriconazole Sandoz | GE | 10173K | A | N | Y | ORAL | 1 | 56 | 0 | 90 | SZ | 56 | 56 | N | 42.13 | 42.13 | N | 4 | N | N | null | null | N | N | 20,450 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-02-01 | N | N | 3,671 |
10173K_8891_1313_5749_39444 | Voriconazole | Voriconazole | Tablet 50 mg | voriconazole 50 mg tablet, 56 | Vttack | GE | 10173K | A | N | Y | ORAL | 1 | 56 | 0 | 142 | AF | 56 | 56 | N | 42.13 | 42.13 | N | 4 | N | N | null | null | N | N | 20,450 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-03-01 | N | N | 3,671 |
10173K_8891_1313_5749_41463 | Voriconazole | Voriconazole | Tablet 50 mg | voriconazole 50 mg tablet, 56 | Vzole | GE | 10173K | A | N | Y | ORAL | 1 | 56 | 0 | 1,081 | RW | 56 | 56 | N | 42.13 | 42.13 | N | 4 | N | N | null | null | N | N | 20,450 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-12-01 | N | N | 3,671 |
10174L_15251_33046_33055_33057 | Enzalutamide | Enzalutamide | Capsule 40 mg | enzalutamide 40 mg capsule, 112 | Xtandi | GE | 10174L | A | N | Y | ORAL | 1 | 112 | 2 | 677 | LL | 112 | 112 | N | 3,150.63 | 3,150.63 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10175M_13366_29107_29110_34911 | Ivacaftor | Ivacaftor | Tablet 150 mg | ivacaftor 150 mg tablet, 56 | Kalydeco | HS | 10175M | A | N | Y | ORAL | 1 | 56 | 5 | 417 | VR | 56 | 56 | N | 20,306.25 | 20,306.25 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10176N_7861_287_15553_38097 | Doxycycline | Doxycycline | Tablet 100 mg (as hyclate) | doxycycline 100 mg tablet, 21 | Doxylin 100 | GE | 10176N | R | N | Y | ORAL | 1 | 21 | 0 | 142 | AF | 21 | 7 | N | 7.5 | 2.5 | N | 4 | N | N | null | null | N | N | 15,555 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-11-01 | N | N | 3,671 |
10176N_7861_287_15553_48449 | Doxycycline | Doxycycline | Tablet 100 mg (as hyclate) | doxycycline 100 mg tablet, 21 | Doxsig | GE | 10176N | R | N | Y | ORAL | 1 | 21 | 0 | 1,081 | RW | 21 | 7 | N | 7.5 | 2.5 | N | 4 | N | N | null | null | N | N | 15,555 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2019-11-01 | N | N | 3,671 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.